Beryl Drugs Limited (BOM:524606)
23.00
0.00 (0.00%)
At close: Aug 18, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 116.65 million as of August 18, 2026. Its market cap has increased by 13.41% in one year.
Market Cap
116.65M
Enterprise Value
138.32M
Revenue
215.51M
Ranking
n/a
PE Ratio
18.39
Stock Price
23.00
ChartMarket Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 116.65M, an increase of 3,057.53%. That is a compound annual growth rate of 17.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 116.65M | -1.71% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Colinz Laboratories | 201.20M |
| Add-Shop E-Retail | 189.41M |
| Zenith Healthcare | 166.05M |
| Norris Medicines | 159.01M |
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 140.84M |
| Ortin Global | 124.25M |
| Unjha Formulations | 123.44M |